Immune cells injected into tumors show promise for skin cancer
Disease control
Recruiting now
This early-phase trial tests whether injecting special immune cells called natural killer (NK) cells directly into skin cancer tumors is safe and can help kill the cancer. It compares two types of NK cells—standard ones and a more powerful type from donors exposed to a common vir…
Phase: EARLY_PHASE1 • Sponsor: Kirsten Johnson • Aim: Disease control
Last updated May 11, 2026 20:40 UTC